EvokAI Creative Labs (TSXV:OKAI) Return-on-Tangible-Equity: 0.00% (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:OKAI EvokAI Creative Labs Inc TSXV:OKAI
15 GF Score
Price C$0.12
View Full Analysis

What is EvokAI Creative Labs Return-on-Tangible-Equity?

EvokAI Creative Labs TSXV:OKAI 15 Return-on-Tangible-Equity is 0.00% as of Sep. 2024. GuruFocus rates TSXV:OKAI with a GF Score™ of 15/100.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. EvokAI Creative Labs's annualized net income for the quarter that ended in Sep. 2024 was C$-1.11 Mil. EvokAI Creative Labs's average shareholder tangible equity for the quarter that ended in Sep. 2024 was C$-1.21 Mil. Therefore, EvokAI Creative Labs's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 was N/A%.

The historical rank and industry rank for EvokAI Creative Labs's Return-on-Tangible-Equity or its related term are showing as below:

TSXV:OKAI's Return-on-Tangible-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.085
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

EvokAI Creative Labs  (TSXV:OKAI) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


EvokAI Creative Labs Return-on-Tangible-Equity Related Terms


EvokAI Creative Labs Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for EvokAI Creative Labs's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EvokAI Creative Labs Return-on-Tangible-Equity Chart

EvokAI Creative Labs Annual Data
Trend Dec21 Dec22 Dec23
Return-on-Tangible-Equity
0.00 0.00 0.00

EvokAI Creative Labs Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -171.51 -756,711.11 0.00 0.00 0.00

TSXV:OKAI vs VEEV, GEHC, DOCS: Return-on-Tangible-Equity Comparison

For the Health Information Services subindustry, EvokAI Creative Labs's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EvokAI Creative Labs Return-on-Tangible-Equity vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EvokAI Creative Labs's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where EvokAI Creative Labs's Return-on-Tangible-Equity falls into.


TSXV:OKAI
15GF Score
EvokAI Creative Labs Inc TSXV:OKAI
Return-on-Tangible-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EvokAI Creative Labs Return-on-Tangible-Equity Calculation

EvokAI Creative Labs's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-22.919/( (-0.897+-0.381 )/ 2 )
=-22.919/-0.639
=N/A %

EvokAI Creative Labs's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=-1.112/( (-1.096+-1.323)/ 2 )
=-1.112/-1.2095
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 0.00% mean?
EvokAI Creative Labs (TSXV:OKAI) has a Return-on-Tangible-Equity of 0.00% as of Sep. 2024. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on EvokAI Creative Labs and its competitors.
Is EvokAI Creative Labs' Return-on-Tangible-Equity too high?
EvokAI Creative Labs' current Return-on-Tangible-Equity is 0.00%. Overall, EvokAI Creative Labs has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does EvokAI Creative Labs' Return-on-Tangible-Equity compare to VEEV and GEHC?
EvokAI Creative Labs' Return-on-Tangible-Equity of 0.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median Return-on-Tangible-Equity is 10.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.09, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on EvokAI Creative Labs and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EvokAI Creative Labs's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EvokAI Creative Labs stock overvalued right now?
EvokAI Creative Labs (TSXV:OKAI) has a current Return-on-Tangible-Equity of 0.00%. The current Return-on-Tangible-Equity is 0.00%. EvokAI Creative Labs' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For EvokAI Creative Labs (TSXV:OKAI), the current Return-on-Tangible-Equity is 0.00% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EvokAI Creative Labs Business Description

Address 609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.
15GF Score

Get the complete analysis for TSXV:OKAI

Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.12
Price